This is why, TLR-9 agonists might be reasonable candidates aimed at stimulating an antitumor response against the malignancy; as an example, CpG oligodeoxynucleotides injection showed strong activity on established AB1 mesothelioma model leading to long-term survival. The gene discussed is TLR9; the disease is mesothelioma.